In patients with HCC, the expression of the stem cell markers CD24 and CD133 correlates with greater iNOS expression and worse outcomes, and higher ADAM17 expression and Notch1 activation correlate with poor prognosis [37]. The gene discussed is ADAM17; the disease is hepatocellular carcinoma.